<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Pfizer and BioNTech Announce Early Positive Data from Coronavirus Vaccine Candidate
Image Overlay - Pfizer and BioNTech Announce Early Positive Data from Coronavirus Vaccine Candidate

Pfizer and BioNTech Announce Early Positive Data from Coronavirus Vaccine Candidate

July 6, 2020

Pfizer and BioNTech Announce Early Positive Data from Coronavirus Vaccine Candidate

Pfizer and BioNTech have shared positive data for their vaccine candidate, which is currently in phase I/II. A week after receiving a second dose, subjects had neutralizing antibodies against SARS-CoV-2 and reported no adverse reactions. A larger, global phase 2b/3 safety and efficacy study may begin as soon as this month. Yourway is a trusted clinical supplies courier, with the logistics experience needed to keep clinical trials running globally.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Media

Articles

Keeping trials on track: Prioritizing communication in decentralized trials

Open chat
Come chat with us!
Hello! How can I help you?